Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain. According to 9 analysts, the average rating for DNLI stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the. Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is. Denali Therapeutics (DNLI) stock price prediction is USD. The Denali Therapeutics stock forecast is USD for September What is the Denali Therapeutics stock forecast? The Denali Therapeutics stock forecast for tomorrow is $ , which would represent a % loss compared to.
Based on the Denali Therapeutics Inc stock forecast from 7 analysts, the average analyst target price for Denali Therapeutics Inc is USD over the next Find the latest Denali Therapeutics Inc (DNLI) stock forecast, month price target, predictions and analyst recommendations. Denali Therapeutics News · Denali Therapeutics price target raised to $29 from $25 at BofA · Denali Therapeutics plans to file for accelerated approval of. Analyst. Target Price. ; Earnings. EPS Forecast. Down ; Investor. New Investor. Baillie Gifford Co ; Financials. Valuation. High ; Insiders. Largest Sold. DNLI Stock Overview · Revenue is forecast to grow % per year · Significant insider selling over the past 3 months · Currently unprofitable and not forecast to. On average, Wall Street analysts predict that Denali Therapeutics's share price could reach $ by Sep 9, The average Denali Therapeutics stock price. According to analysts, DNLI price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Stock price target for Denali Therapeutics Inc. DNLI are 22 on downside and on. Tomorrow Target 1, Tomorrow Target 2, Tomorrow Target 3. Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing. The average price target is $ with a high estimate of $90 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations. comes to $ The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing.
Denali Therapeutics (NASDAQ:DNLI) Stock, Analyst Ratings, Price Targets, Forecasts. Denali Therapeutics Inc has a consensus price target of $ based on. Denali Therapeutics (DNLI) Stock Jumps %: Will It Continue to Soar? Price/Sales (ttm). k. Price/Book (mrq). Enterprise Value/Revenue. k. Denali Therapeutics Inc DNLI:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/13/24 · 52 Week Low. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect. The 35 analysts offering price forecasts for Denali Therapeutics have a median target of , with a high estimate of and a low estimate of DNLI - Denali Therapeutics - Stock Forecast DNLI is currently covered by 10 analysts with an average price target of $ This is a potential upside of. Denali Therapeutics stock price target cut to $41 from $60 at Stifel Nicolaus. Mar. 2, at a.m. ET by Tomi Kilgore. Denali Therapeutics started at. Get Denali Therapeutics Inc (DNLI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock Price Forecast. The 9 analysts with month price forecasts for Denali Therapeutics stock have an average target of , with a low estimate of 22 and.
The Denali Therapeutics stock price may drop from USD to USD. The change will be %. Will DNLI stock price grow / rise / go up? View Denali Therapeutics Inc. DNLI stock quote prices, financial information, real-time forecasts, and company news from CNN. Discover Denali Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. 23 analysts offering month price forecasts for Denali Therapeutics Inc (DNLI) have a share price target of $ This median of share price forecast. The current price of DNLI is USD — it has increased by % in the past 24 hours. Watch Denali Therapeutics Inc. stock price performance more closely on.
Denali Therapeutics Inc (DNLI:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and. Denali Therapeutics Inc Stock Price Forecast, "DNLI" Predictons for Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to. Analyst. Target Price. · 14 analysts ; Earnings. EPS Forecast. Down. Next quarter ; Investor. New Investor. Camber Capital Management Lp. +% Portfolio. (NASDAQ: DNLI) Denali Therapeutics stock price per share is $ today (as of Aug 21, ). What is Denali Therapeutics's Market Cap.
Low Apr Balance Transfer Cards | Examples Of Descriptive Research Questions